Neutral sphingomyelinase 2 induces dopamine uptake through regulation of intracellular calcium

Cellular Signalling

Volumn 22, Issue 5, 2010, Pages 865-870

  Kim, Seok Kyun ^a   Ahn, Kyong Hoon ^a   Ji, Jung Eun ^a   Choi, Jong Min ^a   Jeon, Hyung Jun ^a   Jung, Sung Yun ^a   Jung, Kwang Mook ^a   Kim, Dae Kyong ^a  

^a Chung Ang University   (South Korea)

Author keywords

Calcium; Ceramide; Dopamine uptake; NSMase2; PC12 cells

Indexed keywords

C6 CERAMIDE; C6 DIHYDROCERAMIDE; CALCIUM; CERAMIDE; CERAMIDE DERIVATIVE; EGTAZIC ACID; MESSENGER RNA; SMALL INTERFERING RNA; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN PHOSPHODIESTERASE 2; SPHINGOMYELIN PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG; ANILINE DERIVATIVE; BENZYLIDENE DERIVATIVE; DOPAMINE; GW 4869; NERVE GROWTH FACTOR; SMPD3 PROTEIN, RAT;

ARTICLE; CALCIUM CELL LEVEL; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; DOWN REGULATION; ENZYME ACTIVITY; GENE SILENCING; GENETIC TRANSFECTION; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; DRUG EFFECT; INTRACELLULAR SPACE; METABOLISM; RAT;

ANILINE COMPOUNDS; ANIMALS; BENZYLIDENE COMPOUNDS; CALCIUM; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CERAMIDES; DOPAMINE; EGTAZIC ACID; INTRACELLULAR SPACE; NERVE GROWTH FACTOR; PC12 CELLS; RATS; RNA, SMALL INTERFERING; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSFECTION;

EID: 77951915608     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2010.01.012     Document Type: Article

References (36)

1. Uchikawa T., Kiuchi Y., Yura A., Nakachi N., Yamazaki Y., Yokomizo C., Oguchi K. J. Neurochem. 1995, 65:2065.
2. Giros B., Caron M.G. Trends Pharmacol. Sci. 1993, 14:43.
3. Blakely R.D., Bauman A.L. Curr. Opin. Neurobiol. 2000, 10:328.
4. Hannun Y.A., Obeid L.M. Nat. Rev. Mol. Cell. Biol. 2008, 9(2):139.
5. van Blitterswijk W.J., van der Luit A.H., Veldman R.J., Verheij M., Borst J. Biochem. J. 2003, 369:199.
6. Siskind L.J., Colombini M. J. Biol. Chem. 2000, 275:38640.
7. Siskind L.J., Kolesnick R.N., Colombini M. J. Biol. Chem. 2002, 277:26796.
8. Copeland B.J., Vogelsberg V., Neff N.H., Hadjiconstantinou M. J. Pharmacol. Exp. Ther. 1996, 277:1527.
9. Vaughan R.A., Huff R.A., Uhl G.R., Kuhar M.J. J. Biol. Chem. 1997, 272:15541.
10. Carvelli L., Moron J.A., Kahlig K.M., Ferrer J.V., Sen N., Lechleiter J.D., Leeb-Lundberg L.M., Merrill G., Lafer E.M., Ballou L.M., Shippenberg T.S., Javitch J.A., Lin R.Z., Galli A. J. Neurochem. 2002, 81:859.
11. Huff R.A., Vaughan R.A., Kuhar M.J., Uhl G.R. J. Neurochem. 1997, 68:225.
12. Zhu S., Kavanaugh M.P., Sonders M.S., Amara S.G., Zahniser N.R. J. Pharmacol. Exp. Ther. 1997, 282:1358.
13. Qian Y., Galli A., Ramamoorthy S., Risso S., DeFelice L.J., Blakely N.R. J. Neurosci. 1997, 17:45.
14. Ramamoorthy S., Blakely R.D. Science 1999, 285:763.
15. Riddle E.L., Rau K.S., Topham M.K., Hanson G.R., Fleckenstein A.E. Eur. J. Pharmacol. 2003, 458(1-2):31. 1.
16. Maruyama E.N., Arima M. J. Neurochem. 1989, 52:611.
17. Bernardo K., Krut O., Wiegmann K., Kreder D., Micheli M., Schafer R., Sickman A., Schmidt W.E., Schroder J.M., Meyer H.E., Sandhoff K., Kronke M. J. Biol. Chem. 2000, 275:7641.
18. Jung S.Y., Suh J.H., Park H.J., Jung K.M., Kim M.Y., Na D.S., Kim D.K. J. Neurochem. 2000, 75:1004.
19. Hofmann K., Tomiuk S., Wolff G., Stoffel W. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5895.
20. Marchesini N., Luberto C., Hannun Y.A. J. Biol. Chem. 2003, 278(16):13775.
21. Stoffel A., Chaurushiya M., Singh B., Levine A.J. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9079.
22. Cogolludo A., Moreno L., Frazziano G., Moral-Sanz J., Menendez C., Castañeda J., González C., Villamor E., Perez-Vizcaino F. Cardiovasc. Res. 2009, 82(2):296. 1.
23. Bligh E.G., Dyer W.J. Can. J. Biochem. Physiol. 1959, 37:911.
24. Bloch-Shilderman E., Abu-Raya S., Trembovler V., Boschwitz H., Gruzman A., Linial M., Lazarovici P. J. Pharmacol. Exp. Ther. 2002, 301:953.
25. Jeon H.J., Lee D.H., Kang M.S., Lee M.O., Jung K.M., Jung S.Y., Kim D.K. J. Neurochem. 2005, 95:811.
26. Yoo H.H., Son J., Kim D.H. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 2006, 843(2):327. 7.
27. Chatterjee S. Chem. Phys. Lipids 1999, 102:79.
28. Spence M.W., Burgess J.K. J. Neurochem. 1978, 30:917.
29. Liu B., Hassler D.F., Smith G.K., Weaver K., Hannun Y.A. J. Biol.Chem. 1998, 273:34472.
30. Iversen L. Mol. Psychiatry 2000, 5:357.
31. Masson J., Sagne C., Hamon M., Mestikawy S.E. Pharmacol. Rev. 1999, 51:439.
32. Huang C.L., Huang N.K., Shyue S.K., Chern Y. J. Neurochem. 2003, 86(5):1247.
33. Green K.N., LaFerla F.M. Neuron 2008, 59(2):190.
34. Törnquist K., Blom T., Shariatmadari R., Pasternack M. Biochem. J. 2004, 380(Pt 3):661.
35. Wong K., Li X.-B., Hunchuk N. J. Biol. Chem. 1995, 270:3056.
36. Chik C.L., Li T., Negishi T., Karpinski E., Ho A.K. Endocrinology 1999, 140:5682.